San Diego, CA · Founded 2018 · Privately Held (backing)
Developer of autologous cell therapies and personalized medicines designed for a broad spectrum of diseases, starting with Parkinson's disease. Aspen Neuroscience is based in San Diego, CA and was founded in 2018. Its last reported valuation was $346 million in Sep 2025. It has raised $379 million.
Last reported valuation
$346.0M
Oct 2026
Priced at
—
Total raised
$379.3M
Last round
—
Cap table — not yet on record
Aspen Neuroscience's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Aspen Neuroscience with a free account
·The complete investor list: 26 names
·Watch Aspen Neuroscience: the Monday email on marks, rounds and moves
